Binimetinib is a pharmaceutical raw material that functions as a selective inhibitor of MEK, a key enzyme in the MAPK signaling pathway. It is supplied for use in research and manufacturing of anti-cancer therapeutics.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 606143-89-9
Selumetinib sulfate
pharmaceutical raw material
Bifonazole
pharmaceutical raw material
Grass Valley edit decision list
pharmaceutical raw material
Butylphthalide
pharmaceutical raw material
Elcatonin
pharmaceutical raw material
6-(4-bromo-2-fluoroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide
ACWZRVQXLIRSDF-UHFFFAOYSA-N
CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO